EHCEncompass Health Corporation

$120.75

EHC as reported

Encompass Health Corporation reported $6.21B of revenue over the trailing twelve months, +9.5% on the year before. 10 reported series are charted on this page, each one as filed.

$6.21B

Revenue, trailing twelve months · to Q2 2026 · +9.5% against the twelve months before

Net Income
$621M

Net Income · +19% year on year · trailing twelve months to Q2 2026

Free Cash Flow
$413M

Free Cash Flow · −5.9% year on year · trailing twelve months to Q2 2026

Op Margin
18%

Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for EHC, trailing twelve months
SeriesLatestYear on yearAs of
Revenue$6.21B+9.5%Q2 2026
Net Income$621M+19%Q2 2026
EPS$6.14+20%Q2 2026
Op Margin18%n/aQ2 2026
Net Margin10.0%n/aQ2 2026
ROE24%n/aQ2 2026
ROA8.1%n/aQ2 2026
ROIC17%n/aQ2 2026
Free Cash Flow$413M−5.9%Q2 2026
P/E19.7n/atoday

Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.

Revenue & ProfitEncompass Health Corporation (EHC)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com